Company Filing History:
Years Active: 2019
Title: Tula Raghavan: Innovator in Local Delivery Formulations for Tumor Treatment
Introduction
Tula Raghavan is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical science, particularly in the development of local delivery formulations for treating tumors. His innovative approach aims to enhance the efficacy of treatments while minimizing associated toxicity.
Latest Patents
Raghavan holds a patent for "Local delivery forms of acriflavine for treating tumors." This patent describes local delivery formulations of the antineoplastic and microbicide agent acriflavine. The formulations and methods outlined in the patent demonstrate a significant increase in the median survival of subjects with proliferative disease compared to systemic administrations of acriflavine. The local delivery formulations show a dose-dependent increase in median survival, providing enhanced efficacy without the toxicity linked to systemic administration.
Career Highlights
Tula Raghavan is affiliated with The Johns Hopkins University, where he continues to advance research in the field of cancer treatment. His work focuses on improving therapeutic outcomes for patients suffering from various forms of cancer.
Collaborations
Raghavan collaborates with notable colleagues, including Henry Brem and Antonella Mangraviti. Their combined expertise contributes to the innovative research and development of effective treatment methodologies.
Conclusion
Tula Raghavan's contributions to the field of tumor treatment through local delivery formulations of acriflavine highlight his commitment to improving patient outcomes. His innovative work at The Johns Hopkins University continues to pave the way for advancements in cancer therapy.